沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

未开盘 02-05 16:08:28

6.380

-0.070

-1.09%

最高6.450	最低6.340	成交量71.40万
今开6.360	昨收6.450	日振幅1.71%
总市值42.87亿	流通市值42.87亿	总股本6.72亿
成交额456.03万	换手率0.11%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":6.38,"timestamp":1770278908009,"preClose":6.45,"halted":0,"volume":714000,"delay":0,"changeRate":-0.010852713178294617,"floatShares":672000000,"shares":672000000,"eps":-0.38109488125063495,"marketStatus":"未开盘","change":-0.07,"latestTime":"02-05 16:08:28","open":6.36,"high":6.45,"low":6.34,"amount":4560330,"amplitude":0.017054,"askPrice":6.42,"askSize":1000,"bidPrice":6.38,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":-0.38257678114670196,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":0,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":6.45,"openAndCloseTimeList":[[1770255000000,1770264000000],[1770267600000,1770278400000]],"volumeRatio":0.7876274103250631,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2609309787","title":"明德生物（002932）披露增资并收购蓝怡（湖南）医疗器械有限公司股权进展公告，2月5日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309787","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309787?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:33","pubTimestamp":1770301993,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，明德生物报收于19.26元，较前一交易日上涨0.21%，最新总市值为44.78亿元。公告显示，公司于2026年1月19日召开第五届董事会第三次会议，审议通过增资并收购蓝怡（湖南）医疗器械有限公司股权的议案。截至本公告日，湖南蓝怡已完成工商变更登记，公司持有其51%股权，湖南蓝怡成为公司控股子公司，纳入合并报表范围。嘉善禾欣咨询管理合伙企业受让蓝怡集团持有的湖南蓝怡20%股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1574","BK1222","159883","002932","BK1100","09997","BK0239","09996"],"gpt_icon":0},{"id":"2609309733","title":"陇神戎发（300534）披露取得《医疗器械生产许可证》公告，2月5日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309733?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:27","pubTimestamp":1770301637,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，陇神戎发报收于10.21元，较前一交易日下跌1.64%，最新总市值为30.97亿元。陇神戎发于2026年2月5日发布《关于取得〈医疗器械生产许可证〉的公告》。公告显示，公司于2026年2月5日取得甘肃省药品监督管理局核发的《医疗器械生产许可证》，许可证编号为甘药监械生产许20260001号，生产范围为Ⅲ类：10-04-血液净化及腹膜透析器具，许可期限自2026年2月4日至2031年2月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300534","BK0056","BK0132","159883","09997","09996","BK1574","BK1100","BK1583","BK0239","BK1222"],"gpt_icon":0},{"id":"2609060093","title":"三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证公告，2月5日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609060093","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609060093?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，三鑫医疗报收于9.43元，较前一交易日上涨1.18%，最新总市值为49.23亿元。该股当日开盘9.28元，最高9.6元，最低9.26元，成交额达9887.11万元，换手率为2.9%。近日，三鑫医疗披露《关于控股子公司变更医疗器械生产许可证的公告》。公告显示，公司控股子公司成都威力生生物科技有限公司因生产经营需要，对其《医疗器械生产许可证》的生产地址进行了变更，并取得四川省药品监督管理局换发的新证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK1574","09997","09996","BK1100","BK1583","BK1222","BK0251","159883"],"gpt_icon":0},{"id":"2609632216","title":"陇神戎发(300534.SZ)取得一项医疗器械生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2609632216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609632216?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:41","pubTimestamp":1770280906,"startTime":"0","endTime":"0","summary":"智通财经APP讯，陇神戎发(300534.SZ)公告，公司取得由甘肃省药品监督管理局核发的《医疗器械生产许可证》，本次取得《医疗器械生产许可证》标志着公司血液透析浓缩液(干粉)产品具备生产和上市销售的资质。血液透析浓缩液(干粉)作为血液透析类医疗器械，用于急性肾衰竭、慢性肾衰竭的血液透析治疗，已经被临床广泛应用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300534","BK1574","BK0239","BK1222","BK1583","09996","BK0056","09997","159883","BK1100","BK0132"],"gpt_icon":0},{"id":"2609341181","title":"海南自贸港医疗器械保税维修业务实现全流程闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=2609341181","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609341181?lang=zh_cn&edition=full","pubTime":"2026-02-05 11:52","pubTimestamp":1770263520,"startTime":"0","endTime":"0","summary":"海口海关5日披露，首批适用“执行例外措施”政策的区外保税维修货物近日在海口国家高新区完成全部维修流程，从海口美兰机场口岸复运出境。这标志着海南自贸港医疗器械保税维修业务首次实现“进口—维修—复运出境”全流程闭环。海口海关表示，下一步将推动医疗器械、航空器材、精密仪器等高端保税维修业态在琼集聚发展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-05/doc-inhktspr3090560.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-05/doc-inhktspr3090560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1222","BK1100","09997","BK1574","159883","BK1583","09996"],"gpt_icon":0},{"id":"2608362077","title":"复星医药：公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362077","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608362077?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:37","pubTimestamp":1770212245,"startTime":"0","endTime":"0","summary":"证券日报网讯2月4日，复星医药在互动平台回答投资者提问时表示，公司自1994年创立于上海，是一家植根中国、创新驱动的全球化医药健康产业集团。目前，公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务；其中，制药是公司的核心主营业务，也是公司品牌建设的重要承载。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043641720167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159760","BK0060","BK4585","BK1222","01477","BK0028","BK0183","BK0187","XBI","BK1515","BK0188","BK0175","BK1593","02196","BK4588","09996","BK0239","BK0096","LABU","BK0196","BK1583","BK1191","09997","XLV","BK1100","600196","BK0012","BK1574","BK4581","159883"],"gpt_icon":0},{"id":"2608359486","title":"心脉医疗(688016.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2608359486","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608359486?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:47","pubTimestamp":1770194847,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布公告，近日，公司的全资子公司上海拓脉医疗科技有限公司(简称“拓脉医疗”)获得国家药品监督管理局颁发的关于聚乙烯醇栓塞微球的医疗器械注册证。该产品适用于富血管型实质性器官恶性肿瘤的栓塞治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","159883","09997","BK1574","BK1222","09996","BK0251","BK1583","688016"],"gpt_icon":0},{"id":"2609419423","title":"每日卖空追踪 | 沛嘉医疗-B 02月04日卖空量成交2.6万股，卖空比例为3.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609419423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609419423?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193843,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月04日，涨0.47%，卖空量成交2.6万股，较上一交易日减少23.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163909a6d20753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163909a6d20753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","09996","BK1574"],"gpt_icon":0},{"id":"2608356852","title":"红日药业：公司业务布局可大致分为中药配方颗粒、成品药、医疗器械、原辅料、医疗健康服务和药械智慧供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2608356852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608356852?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:12","pubTimestamp":1770192736,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业02月04日在投资者关系平台上答复投资者关心的问题。公司在巩固核心产品市场地位的同时，积极推动配方颗粒业务提质增效，以应对集采政策影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400025235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK1222","159760","BK0239","BK1583","BK1574","09997","159883","BK0188","BK0077","BK1100","09996"],"gpt_icon":0},{"id":"2608355389","title":"山东省泰安市泰山区市场监管局扎实开展医疗器械专项抽检工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2608355389","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608355389?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:36","pubTimestamp":1770190560,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯近日，泰山区市场监管局紧扣问题导向、靶向监管原则，全面启动2026年第一轮医疗器械省级专项抽检工作。下一步，泰山区市场监管局将持续深化医疗器械精准监管模式，充分发挥监督抽检的技术支撑和风险预警作用，加大对重点领域、重点主体的常态化监管力度，筑牢医疗器械质量安全防线，切实保障人民群众用械安全、有效、放心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-04/doc-inhkrtwm6639711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","09997","BK1222","BK1100","159883","09996","BK1574"],"gpt_icon":0},{"id":"2608303334","title":"辽宁省锦州市市场监管局三举措优化医疗器械类审批服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2608303334","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608303334?lang=zh_cn&edition=full","pubTime":"2026-02-04 13:07","pubTimestamp":1770181620,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 近日，辽宁省锦州市市场监督管理局行政审批二科分别获得医疗器械生产企业和经营企业赠送两面锦旗。医疗器械类审批工作依托国家药监局政务服务门户，实现“全程网上办、一次不用跑”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-04/doc-inhkrpqk3045436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1222","BK1583","09997","BK1100","159883","09996"],"gpt_icon":0},{"id":"2608381651","title":"北京协和医院“小伙伴”，麻醉监护医疗器械小巨人海圣医疗今日申购丨打新早知道","url":"https://stock-news.laohu8.com/highlight/detail?id=2608381651","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608381651?lang=zh_cn&edition=full","pubTime":"2026-02-04 07:00","pubTimestamp":1770159600,"startTime":"0","endTime":"0","summary":"2月4日，可申购北交所的海圣医疗。该公司自成立以来持续深耕麻醉和监护医用耗材的研发和制造，是我国较早从事麻醉和监护类医用耗材研发制造的科技型医疗器械生产企业之一，是国家级专精特新“小巨人”企业，已搭建起麻醉类、监护类、手术及护理类三大类产品矩阵。此外，公司产品已成功销往境外主要国家和地区。投资者据此操作，风险自担。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-04/doc-inhkrayr9876723.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-04/doc-inhkrayr9876723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1222","BK1574","159891","09996","09997","159883","BK1100"],"gpt_icon":0},{"id":"2608827668","title":"每日卖空追踪 | 沛嘉医疗-B 02月03日卖空量成交2.1万股，卖空比例为3.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608827668?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107442,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月03日，涨2.88%，卖空量成交2.1万股，较上一交易日减少70.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163758a476c5e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163758a476c5e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2608840720","title":"新华医疗(600587.SH)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2608840720","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608840720?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:36","pubTimestamp":1770104181,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗(600587.SH)公告，公司全资子公司新华医疗康复产业(西安)有限公司于近日收到陕西省药品监督管理局颁发的《医疗器械注册证》，相关产品名称为：四肢联动康复训练仪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0028","BK1574","BK0251","BK1222","600587","BK1583","BK1100","09996","09997","159883"],"gpt_icon":0},{"id":"2608840502","title":"香港卫生署：今年将成为中国香港药械创新监管里程碑 实现“好药港用、好械港用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2608840502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608840502?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:17","pubTimestamp":1770103075,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月3日，香港卫生署署长林文健医生在参加药物及医疗器械（药械）监管研讨会时表示，2026年将成为中国香港药械创新监管发展的里程碑。建立“第一层审批”机制可加快创新药械的开发，实现“好药港用、好械港用”。此外，香港卫生署已于去年十二月开始为有意递交“1+”机制下新药注册申请者提供“一对一”会面咨询服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","09997","BK1574","BK1222","09996"],"gpt_icon":0},{"id":"2608827646","title":"沛嘉医疗-B盘中异动 股价大涨5.45%报6.580港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608827646?lang=zh_cn&edition=full","pubTime":"2026-02-03 09:36","pubTimestamp":1770082569,"startTime":"0","endTime":"0","summary":"2026年02月03日早盘09时36分，沛嘉医疗-B股票出现异动，股价大幅上涨5.45%。截至发稿，该股报6.580港元/股，成交量5000股，换手率0.00%，振幅2.56%。资金方面，该股资金流入6580港元，流出0港元。沛嘉医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.11%。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203093609a6cc323f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203093609a6cc323f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1574","BK1100","BK1583"],"gpt_icon":0},{"id":"2608290867","title":"三鑫医疗（300453）披露全资子公司变更医疗器械生产许可证公告，2月2日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608290867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608290867?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:32","pubTimestamp":1770042743,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，三鑫医疗报收于9.13元，较前一交易日下跌2.04%，最新总市值为47.67亿元。近日，三鑫医疗披露《关于全资子公司变更医疗器械生产许可证的公告》。公告显示，公司全资子公司云南三鑫医疗科技有限公司因注销医用外科口罩、医用防护口罩、一次性使用医用口罩三项医疗器械注册证，相应变更《医疗器械生产许可证》生产范围，并取得云南省药品监督管理局换发的新证。该事项不会对公司生产经营产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1574","159883","BK1100","09996","09997","300453","BK1222","BK1583"],"gpt_icon":0},{"id":"2608427857","title":"微电生理（688351）披露一次性使用心腔内超声成像导管获医疗器械注册证，2月2日股价下跌3.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608427857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608427857?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:59","pubTimestamp":1770026382,"startTime":"0","endTime":"0","summary":"近日，上海微创电生理医疗科技股份有限公司发布公告称，公司的一次性使用心腔内超声成像导管获得国家药品监督管理局颁发的医疗器械注册证，注册证编号为国械注准20263060230，有效期至2031年1月28日。该产品适用于与便携式数字化彩色超声诊断仪配合使用，用于心脏及心脏大血管、心内解剖结构的超声成像；与三维心脏电生理标测系统配合使用时，可提供导管定位信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200027220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","159883","BK1222","BK1583","688351","BK1574","BK1100","BK0251","09996"],"gpt_icon":0},{"id":"2608856236","title":"微电生理(688351.SH)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2608856236","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608856236?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:14","pubTimestamp":1770020047,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微电生理(688351.SH)公告，公司产品一次性使用心腔内超声成像导管于近日获得了国家药品监督管理局颁发的《医疗器械注册证》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","159883","BK1222","BK1583","688351","BK1574","BK1100","BK0251","09996"],"gpt_icon":0},{"id":"2608884028","title":"A股申购 | 爱得科技(920180.BJ)开启申购 主要从事以骨科耗材为主的医疗器械的研发、生产与销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608884028?lang=zh_cn&edition=full","pubTime":"2026-02-02 06:29","pubTimestamp":1769984982,"startTime":"0","endTime":"0","summary":"招股书显示，爱得科技主要从事以骨科耗材为主的医疗器械的研发、生产与销售，主要产品包括脊柱类、创伤类、运动医学等骨科医用耗材以及用于伤口疗愈的创面修复产品。截至招股说明书签署日，公司及其子公司共拥有 132 项产品备案或注册证，其中 I 类产品备案 62 项，II 类产品注册证 34 项，III 类产品注册证 35 项，代理进口医疗器械产品 1 项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","399300","BK1222","BK1574","09996","09997","159883","BK1100","159982"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.052},{"period":"1month","weight":-0.0124},{"period":"3month","weight":0.1019},{"period":"6month","weight":-0.2581},{"period":"1year","weight":0.7871},{"period":"ytd","weight":0.0616}],"compareEarnings":[{"period":"1week","weight":-0.0387},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0245},{"period":"6month","weight":0.0815},{"period":"1year","weight":0.3053},{"period":"ytd","weight":0.049}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.027363},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}